title: Chlamydia-psittaci-eradicating antibiotic therapy in patients with advanced-stage ocular adnexal MALT lymphoma.
authors: A J M
authors: AJ
authors: Ferreri
authors: G P
authors: GP
authors: Dognini
authors: M
authors: M
authors: Ponzoni
authors: L
authors: L
authors: Pecciarini
authors: M G
authors: MG
authors: Cangi
authors: G
authors: G
authors: Santambrogio
authors: A G
authors: AG
authors: Resti
authors: C
authors: C
authors: De Conciliis
authors: S
authors: S
authors: Magnino
authors: E
authors: E
authors: Pasini
authors: N
authors: N
authors: Vicari
authors: R
authors: R
authors: Dolcetti
authors: C
authors: C
authors: Doglioni
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002691:Chlamydophila psittaci / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D009956:Psittacosis / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction; D040521:Subcutaneous Tissue
chemical_list: D000900:Anti-Bacterial Agents; D004318:Doxycycline